About
Joined Biomed in 2022 with a background in scientific innovation and early entrepreneurship. Previously developed the business case for the ETH Zurich spin-off Emuna Therapeutics. Holds a Doctor of Sciences from ETH Zurich.
Contact· self-published, not guessed
Experience
- BiomedVCInvestment Managercurrent2022 — presentBasel, Switzerland
- NXI Therapeutics AGBoard Observercurrent2026 — presentBasel, Switzerland
- OmnilinX TherapeuticsBoard Observercurrent2026 — presentMunich, Germany
- T-CURX GmbHBoard Observercurrent2025 — presentWürzburg, Germany
- iDEL Therapeutics GmbHBoard Observercurrent2025 — presentDortmund, Germany
- Salvina TherapeuticsBoard Observercurrent2024 — presentZürich, Switzerland
- Dimericon TherapeuticsBoard Observercurrent2023 — presentHorgen, Switzerland
- Venture KickJury Membercurrent2026 — presentSchlieren, Switzerland
- ETH ZürichEmuna Therapeutics: Innosuisse Innovation Project Leader & SNF BRIDGE Proof of Concept Fellow2019 — 2022Zurich, Switzerland
- ETH ZürichResearch Scientist: Doctoral & Postdoctoral Researcher2014 — 2019Zurich, Switzerland
Skills & more
- Financial Modeling & Valuation Analyst — Corporate Finance Institute
- Innosuisse Business Creation Biotech — Venturelab
From Morgan's professional profile.
Colleagues at BioMedPartners
Aristotelis Nastos
Managing Partner at BioMedPartners
Claudia Ulbrich
Venture Partner at BioMedPartners
David Urech
Venture Partner at BioMedPartners
Dr. Aristotelis Nastos
Managing Partner at BioMedPartners
Dr. Claudia Ulbrich
Venture Partner at BioMedPartners
Dr. David Urech
Venture Partner at BioMedPartners
Dr. Marianna Feretzaki
Senior Associate at BioMedPartners
Dr. Markus Hosang
Managing Partner at BioMedPartners
Frequently asked questions
- Who is Morgan Hunter?
- Joined Biomed in 2022 with a background in scientific innovation and early entrepreneurship. Previously developed the business case for the ETH Zurich spin-off Emuna Therapeutics. Holds a Doctor of Sciences from ETH Zurich.
- Where does Morgan Hunter work?
- Morgan Hunter is Investment Manager at BioMedPartners.
- Where did Morgan Hunter go to school?
- Morgan Hunter studied at ETH Zürich (Doctor of Sciences (Dr. Sc. ETH Zurich)); Rhodes University (Master of Science (MSc), Biochemistry); Rhodes University (Bachelor of Science Honours (BSc Hons), Biotechnology).
Same school
Also attended ETH Zürich227
Bastian HasslingerInvestor at Index VenturesCat WuInvestor at Index VenturesKJ SidberryInvestor at GV (Google Ventures)Steve VassalloInvestor at Foundation CapitalHelge DaebelPartner, Head of Water at Emerald Technology Ventures AgMaurin DaiInvestment Manager, Physical AI & Robotics at Emerald Technology Ventures Ag
+ 221 more
Also attended Rhodes University12
Tom NicholsonSenior Analyst at PeakBridge VCByron AndersonOperations / Finance at Standard CryptoBrendon GrunewaldGrowth – Data Sovereignity – Finance at AngelwiseLincoln WahlChief Financial Officer at FederationKristina McDougallAdvisor at RiSC Capital CorpMohamed CassimChief Investment Officer at Africa Climate Ventures
+ 6 more
Shared employers
Also worked at T-CURX GmbH2
Also worked at iDEL Therapeutics GmbH1
Also worked at ETH Zürich95
Max HeftiInvestment Director - Energy at Emerald Technology Ventures AgMichal NatoraSenior Investment Director - Industrial IT & Robotics at Emerald Technology Ventures AgAnnina WinklerSenior Investment Manager - Water & AgriFood at Emerald Technology Ventures AgAndreas GuggenbühlInvestor at Backbone VenturesJoel RoosInvestor at Backbone VenturesPaola BranniInvestor at Extantia Capital
+ 89 more